By Kathy Katella, October 1, 2024 A new highly transmissible coronavirus subvariant is starting to spread in the United States. Experts say it could become the dominant SARS-CoV-2 strain just in time for winter, when COVID-19 infections and hospitalizations tend to peak. …
Comparing the COVID-19 Vaccines: How Are They Different?
By Kathy Katella, September 3, 2024 COVID-19 is now in its fifth year, and the subvariants of the Omicron strain continue to drive infections in the United States. The good news is that vaccines, which have been updated each year since 2022, …
3 Things to Know About FLiRT, the New Coronavirus Strains
By Kathy Katella, June 7, 2024 A Yale Medicine expert weighs in on the potential impact of the new strains on the spread of COVID. The good news is that in the early spring of 2024, COVID-19 cases were down, with far …
FDA authorizes COVID drug Pemgarda for high-risk patients
By Carrie Macmillian, Yale Medicine, April 5, 2024 The Food and Drug Administration (FDA) granted an emergency use authorization (EUA) to a medicine meant to protect certain immunocompromised people against COVID-19. The medicine, pemivibart (brand name Pemgarda™), is for people …
13 things to know about Paxlovid, the latest COVID-19 pill
Kathy Katella, Yale Medicine, March 25, 2024 Paxlovid, an oral antiviral pill that can be taken at home, is the go-to treatment for COVID-19. If you are at high risk for severe disease from COVID, and you take it within the …